Skip to main content
SpringerLink
Log in

Multi-resistant Enterobacteriaceae in Hospital Practice

  • Chapter
Reemergence of Established Pathogens in the 21st Century

Part of the book series: Emerging Infectious Diseases of the 21st Century ((EIDC,volume 2))

  • 119 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham, E. P., & Chain, E. (1940). An enzyme from bacteria able to destroy penicillin. Nature, 146, 837.

    CAS  Google Scholar 

  • Aksaray, S., Dokuzo-Guz, B., Guvener, E., Yucesoy, M., Yulug, N., Kocagoz, S., Unal, S., Cetin, S., Calangu, S., Gunaydin, M., Leblebicioglu, H., Esen, S., Bayar, B., Willke, A., Findik, D., Tuncer, I., Baysal, B., Gunseren, F., & Mamikoglu, L. (2000). Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in a hight hospital in Turkey. J Antimicrob Chemother, 45, 695–699.

    Article  PubMed  CAS  Google Scholar 

  • Alonso, A., Sanchez, P., & Martinez, J. L. (2001). Environmental selection of antibiotic resistance genes. Environ Microbiol, 3, 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Alves, A. M., Lasaro, M. O., Almeida, D. F., & Ferreira, L. C. (2000). DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC). Vaccine, 19, 788–795.

    Article  PubMed  CAS  Google Scholar 

  • Ambler, R. P. (1980). The structure of β-lactamases. Phil Trans R Soc Lond Biol, 289, 321–331.

    CAS  Google Scholar 

  • Andersson, D. I., & Levin, B. R. (1999). The biological cost of antibiotic resistance. Curr Opin Microbiol, 2, 489–493.

    PubMed  CAS  Google Scholar 

  • Archival, L., Phillips, L., Monnet, D., McGowan, J. E. J., Tenover, F., & Gaynes, R. (1997). Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clin Infect Dis, 24, 211–215.

    Google Scholar 

  • Arlet, G., Rouveau, M., Casin, I., Bouvet, P. J. M., Lagrange, P. H., & Philippon, P. (1994). Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol, 32, 2553–2558.

    PubMed  CAS  Google Scholar 

  • Asensio, A., Oliver, A., González-Diego, P., Baquero, F., Pérez-Díaz, J. C., Ros, P., Cobo, J., Palacios, M., Lasheras, D., & Cantón, R. (2000). Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection. Clin Infect Dis, 30, 55–60.

    Article  PubMed  CAS  Google Scholar 

  • Ballow, C. H., & Schentag, J. J. (1992). Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis, 15, 37S–42S.

    Article  PubMed  CAS  Google Scholar 

  • Banberger, D. M., & Dahl, S. L. (1992). Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch Intern Med, 152, 554–557.

    Google Scholar 

  • Baquero, F., Negri, M. C., Morosini, M. I., & Blázquez, J. (1998). Antibiotic-selective environments. Clin Infect Dis, 27, S5–S11.

    Article  PubMed  Google Scholar 

  • Barnaud, G., Arlet, G., Verdet, C. H., Gaillot, O., Lagrange, P. H., & Philippon, A. (1998). Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother, 42, 2352–2358.

    PubMed  CAS  Google Scholar 

  • Bennet, P. M. (1999). Integrons and gene cassetes: A genetic construction kit for bacteria. J Antimicrob Chemother, 43, 1–4.

    Google Scholar 

  • Berger, J. M., Gamblin, S. J., Harrison, S. C., & Wang, J. C. (1996). Structure and mechanism of DNA topoisomerase II. Nature, 379, 225–232.

    PubMed  CAS  Google Scholar 

  • Berlanga, M., Vazquez, J. L., Hernandez-Borrell, J., Montero, M. T., & Viñas, M. (2000). Evidence of an efflux pump in Serratia marcescens. Microb Drug Resist Mech E Dis, 6, 111–117.

    CAS  Google Scholar 

  • Björkman, J., & Andersson, D. I. (2000). The cost of antibiotic resistance from a bacterial perspective. Drug Resist Updat, 3, 237–245.

    PubMed  Google Scholar 

  • Blázquez, J., Morosini, M. I., Negri, M. C., & Baquero, F. (2000). Selection of naturally occurring extended-spectrum TEM β-lactamase variants by fluctuating β-lactam pressure. Antimicrob Agents Chemother, 44, 2182–2184.

    PubMed  Google Scholar 

  • Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997). Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci, USA, 94, 12106–12111.

    PubMed  CAS  Google Scholar 

  • Bonten, M. J. M., & Weinstein, R. A. (1996). The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol, 17, 193–200.

    PubMed  CAS  Google Scholar 

  • Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev, 14, 933–951.

    Article  PubMed  CAS  Google Scholar 

  • Bradford, P. A., Cherubin, C. E., Idemyor, V., Rasmussen, B. A., & Bush, K. (1994). Multiply resistant Klebsiella pneumoniae from two Chicago hospitals: Identification of the extended-spectrum β-lactamase TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob Agents Chemother, 38, 761–766.

    PubMed  CAS  Google Scholar 

  • Bradford, P. A., Urban, C., Mariano, N., Projam, S. J., Rahal, J. J., & Bush, K. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of outer membrane protein. Antimicrob Agents Chemother, 41, 563–569.

    PubMed  CAS  Google Scholar 

  • Burke, J. P. (1998). Antibiotic-resistance—squeezing the balloon? JAMA, 280, 1270–1271.

    PubMed  CAS  Google Scholar 

  • Bush, K. (1989). Characterization of β-lactamases. Antimicrob Agents Chemother, 33, 259–263.

    PubMed  CAS  Google Scholar 

  • Bush, K. (1997). The evolution of beta-lactamases. Ciba Found Symp, 207, 152–163.

    PubMed  CAS  Google Scholar 

  • Bush, K. (1999). β-lactamases of increasing clinical importance. Curr Pharmaceut Des, 5, 839–845.

    CAS  Google Scholar 

  • Bush, K. (2001). New beta-lactamases in Gram-negative bacteria: Diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis, 32, 1085–1089.

    Article  PubMed  CAS  Google Scholar 

  • Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995). A functional classificatio scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 39, 1211–1233.

    PubMed  CAS  Google Scholar 

  • Byl, B., Clevenbergh, P., Jacobs, F, Struelens, M. J., Zech, F., Kentos, A., & Thys, J. P. (1999). Impact of infectious disease specialist and microbiological data on the appropriateness of antimicrobial therapy for bacteriemia. Clin Infect Dis, 29, 60–66.

    PubMed  CAS  Google Scholar 

  • Cantón, R., Pérez-Vázquez, M. P., Oliver, A., Coque, T. M., Loza, E., Ponz, F., & Baquero, F. (2001). Validation of the VITEK2 and the Advance Expert System with a Collection of Enterobacteriaceae harboring Extended Spectrum or Inhibitor Resistant β-lactamases. Diagn Microbiol Infect Dis, 41, 65–70.

    PubMed  Google Scholar 

  • Carattoli, A., Villa, L., Pezzella, C., Bordi, E., & Visca, P. (2001). Expanding drug resistance through integron acquisition by IncFI plasmids of Salmonella Enterica Typhimurium. Emerg Infect Dis, 7, 444–447.

    PubMed  CAS  Google Scholar 

  • Chang, Y, Siu, L. K., Fung, C. P., Huang, M. H., & Ho, M. (2001). Diversity of SHV and TEM β-lactamases in Klebsiella pneumoniae: Gene evolution in northern Taiwan and two novel β-lactamases SHV-25 and SHV-26. Antimicrob Agents Chemother, 45, 2407–2413.

    Article  PubMed  CAS  Google Scholar 

  • Chiew, Y. F., Yeo, S. F., Hall, L. M. C., & Livermore, D. (1998). Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae. J Antimicrob Chemother, 41, 247–251.

    Article  PubMed  CAS  Google Scholar 

  • Chu, Y. W., Houang, E. T. S., & Cheng, A. F. B. (1998). Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants. Antimicrob Agents Chemother, 42, 3051–3052.

    PubMed  CAS  Google Scholar 

  • Conlan, J. W., Kuo-Lee, R., Webb, A., Cox, A. D., & Perry, M. B. (2000). Oral immunization of mice with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157∶H7 admixed with cholera toxin fails to elicit protection against subsequent colonization by the pathogen. Can J Microbiol, 46, 283–290.

    Article  PubMed  CAS  Google Scholar 

  • Conrad, S. M., Oethinger, M., Kaifel, K., Klotz, G., Marre, R., & Kern, W. V (1994). gyrA mutations in high-level fluoroquinolone-resistant Escherichia coli clinical isolates. J Antimicrob Chemother, 38, 443–455.

    Google Scholar 

  • Coque, T. M., Valera, M. C., Oliver, A., Morosini, M. I., & Cantón, R. (2001). Shifting epidemiology of extended-spectrum beta-lactamases (ESBL) in a Spanish hospital (1988–2000): From SHV to CTXM derivel ESBL. In Programs and abstracts 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology.

    Google Scholar 

  • Coque, T. M., Oliver, A., Pérez-Díaz, J. C., Baquero, F., & Cantón, R. (2002). Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended Spectrum β-Lactamases are Carried by Multiple Klebsiella pneumoniae Clones in a Single Hospital (Madrid, 1989–2000). Antimicrob Agents Chemother, 46, 500–510.

    Article  PubMed  CAS  Google Scholar 

  • Cornaglia, G., Roussel, K., Satta, G., & Fontana, R. (1995). Relative importances of outer membrane permeability and group 1 β-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Antimicrob Agents Chemother, 39, 350–355.

    PubMed  CAS  Google Scholar 

  • Datta, N., & Kontomichalou, P. (1965). Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature, 208, 239–241.

    PubMed  CAS  Google Scholar 

  • Datta, N., & Hughes, V M. (1983). Plasmids of the same Inc groups in Enterobacteria before and after the medical use of antibiotics. Nature, 306, 616–617.

    Article  PubMed  CAS  Google Scholar 

  • Davies, J. E. (1997). Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found Symp, 207, 15–27.

    PubMed  CAS  Google Scholar 

  • De Gheldre, Y., Struelens, M. J., Glupczynski, Y., De Mol, P., Maes, N., Nonhoff, C., Chetoui, H., Sion, C., Ronveaux, O., Vaneechoutte, M., & le Groupement Pour Le Dépistage, ĽEtude et la Prevencion de Infections Hospitalières (GDEPIH-GOSPIZ). (2001). National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol, 39, 889–896.

    PubMed  Google Scholar 

  • De Man, P., Verhoeven, B. A., Verbrugh, H. A., Vos, M. C., & van den Anker, J. N. (2000). An antibiotic policy to prevent emergence of resistant bacilli. Lancet, 355, 973–978.

    PubMed  Google Scholar 

  • Dennesen, P. J., Bonten, M. J., & Weinstein, R. A. (1998). Multiresistant bacteria as a hospital epidemic problem. Ann Med, 30, 176–185.

    PubMed  CAS  Google Scholar 

  • Domínguez, E. A., Smith, T. L., Reed, E., Sanders, C. C., & Sanders, W. E., Jr. (2000). A pilot study of antibiotic cycling in a hematology-oncology unit. Infect Control Hosp Epidemiol, 21, S4–S8.

    PubMed  Google Scholar 

  • Drlica, K., & Zhao, X. L. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev, 61, 377–392.

    PubMed  CAS  Google Scholar 

  • Drusano, G. L. (2000). Fluoroquinolone pharmacodynamics: Prospective determination of the relationships between exposure and outcome. J Chemother, 12, S21–S26.

    Google Scholar 

  • El-Hajj, H. H., Marras, S. A., Tyagi, S., Kramer, F. R., & Alland, D. (2001). Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol, 39, 4131–4137.

    Article  PubMed  CAS  Google Scholar 

  • Essack, E. S., Hall, L. M. C., Pillay, D. G., McFadyen, M. L., & Livermore, D. M. (2001). Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob Agents Chemother, 45, 88–95.

    Article  PubMed  CAS  Google Scholar 

  • Evans, R. S., Classen, D. C., Pestonik, S. L., Lundsgaarde, H. P., & Burke, J. P. (1994). Improving antibiotic selection using computer decision support. Arch Intern Med, 154, 878–884.

    Article  PubMed  CAS  Google Scholar 

  • Everett, M. J., Jin, Y. F., Ricci, V., & Piddock, L. J. V (1996). Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother, 40, 2380–2386.

    PubMed  CAS  Google Scholar 

  • Fernández-Rodríguez, A., Cantón, R., Pérez-Díaz, J. C., Martínez-Beltrán, J., Picazo, J. J., & Baquero, F. (1992). Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum β-lactamases. Antimicrob Agents Chemother, 36, 2536–2538.

    PubMed  Google Scholar 

  • Fiett, J., Palucha, A., Miaczynska, B., Stankiewicz, M., Przondo-Mordaska, H., Hryniewicz, W., & Gniadkowski, M. (2000). A novel complex mutant β-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended spectrum β-lactamase-producing Klebsiellae. Antimicrob Agents Chemother, 44, 1499–1505.

    Article  PubMed  CAS  Google Scholar 

  • Fish, D. N., Piscitelli, S. C., & Danziger, L. H. (1995). Development of resistance during antimicrobial therapy: A review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy, 15, 279–291.

    PubMed  CAS  Google Scholar 

  • Fix, A. M., Pfaller, M. A., Biedenbach, D. J., Beach, M. L., & Jones, R. N. (2001). Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development. Int J Antimicrob Agents, 18, 141–145.

    PubMed  CAS  Google Scholar 

  • Fluit, A. C., Schmitz, F. J., Verhoef, J., & European SENTRY participants. (2001). Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. In J Antimicrob Agents, 18, 147–160.

    CAS  Google Scholar 

  • Frank, M. O., Batteiger, B. E., Sorensen, S. J., Hartstein, A. I., Carr, J. A., McComb, J. S., Clark, C. D, Abel, S. R., Mikuta, J. M., & Jones, R. B. (1997). Decreased in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improved program. Clin Perform Quality Health Care, 5, 180–188.

    CAS  Google Scholar 

  • Fridkin, S. K., & Gaynes, R. P. (1999). Antimicrobial resistance in intensive care units. Clin Chest Med, 20, 303–315.

    Article  PubMed  CAS  Google Scholar 

  • Fridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, J. E., Jr, Archivald, L. K., Gaynes, R. P., & Tenover, F. C. (1999). Surveillance of antimicrobial use and resistance in US hospitals: Project ICARE phase 2: project intensive care antimicrobial resistance epidemiology (ICARE) hospitals. Clin Infect Dis, 29, 245–252.

    PubMed  CAS  Google Scholar 

  • Friedman, S. M., Lu, T., & Drlica, K. (2001). Mutation in DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region. Antimicrob Agents Chemother, 45, 2378–2380.

    Article  PubMed  CAS  Google Scholar 

  • Galdbart, J. O., Lémann, F., Ainouz, D., Féron, P., Lambert-Zechovsky, N., & Branger, C. (2000). TEM-24 extended-spectrum β-lactamase-producing Enterobacter aerogenes: Long-term clonal dissemination in French hospitals. Clin Microbiol Infect, 6, 316–323.

    Article  PubMed  CAS  Google Scholar 

  • Garau, J., Xercavins, M., Rodríguez-Caballeira, M., Gómez-Vera, J. R., Coll, I., Vidal, D., Llovet, T., & Ruiz-Bremon. A. (1999). Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother, 43, 2736–2741.

    PubMed  CAS  Google Scholar 

  • Gaynes, R., & Monnet, D. (1997). The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals. Ciba Found Symp, 207, 47–60.

    PubMed  CAS  Google Scholar 

  • Gerding, D. N. (2000). Antimicrobial cycling: Lessons learned from aminoglycoside experience. Infect Control Hosp Epidemiol, 21, S12–S17.

    PubMed  CAS  Google Scholar 

  • Gerding, D. N., Larson, T. A., Hughes, R. A., Weiler, M., Shanholtzer, C., & Peterson, L. R. (1991). Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital. Antimicrob Agents Chemother, 35, 1284–1290.

    PubMed  CAS  Google Scholar 

  • Giakkoupi, P., Tzouvelekis, L. S., Tsakris, A., Loukova, V., Sofianou, D., & Tzelepi, E. (2000). IBC-1, a novel integron-associated class A β-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother, 44, 2247–2253.

    Article  PubMed  CAS  Google Scholar 

  • Giamarellou, H., & Antoniadou, A. (1997). The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital. Ciba Found Symp, 207, 76–86.

    PubMed  CAS  Google Scholar 

  • Giraud, E., Cloeckaert, A., Kerboeuf, D., & Chaslus-Dancla, E. (2000). Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother, 44, 1223–1228.

    Article  PubMed  CAS  Google Scholar 

  • Gniadkowski, M., Palucha, A., Grzesiowsk, P., & Hryniewicz, W. (1998a). Outbreak of ceftazidime-resistant Klebsiella pneumoniae in Warsaw, Poland: Clonal spread of the TEM-47 extended spectrum β-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5 like ESBL-encoding gene. Antimicrob Agents Chemother, 42, 3079–3085.

    PubMed  CAS  Google Scholar 

  • Gniadkowski, M., Schneider, I., Jungwirth, R., Hryniewicz, W., & Bauernfeind, A. (1998b). Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: Identification of three novel TEM-and SHV-5 type extended spectrum β-lactamase-producing Klebsiellae. Antimicrob Agents Chemother, 42, 514–520.

    PubMed  CAS  Google Scholar 

  • Gomez-Lus, R. (1998). Evolution of bacterial resistance to antibiotics during the last three decades. Int Microbiol, 1, 279–284.

    PubMed  CAS  Google Scholar 

  • Gould, I. (1999). A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother, 43, 459–465.

    PubMed  CAS  Google Scholar 

  • Goussard, S., Sougakoff, W., Mabilat, C., Bauernfeind, A., & Courvalin, P. (1991). An IS1-like element is responsible for high-level synthesis of extended-spectrum β-lactamase TEM-6 in Enterobacteriaceae. J Gen Microbiol, 137, 2681–2687.

    PubMed  CAS  Google Scholar 

  • Gruson, D., Hilbert, G., Vargas, F., Valentino, R., Bebear, C., Allery, A., Bebear, C., Gbikpi-Benisson, G., & Cardinaus, J. P. (2000). Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Am J Respir Crit Care Med, 162, 837–843.

    PubMed  CAS  Google Scholar 

  • Guillemot, D. (1999). Antibiotic use in humans and bacterial resistance. Curr Opin Microbiol, 2, 494–498.

    Article  PubMed  CAS  Google Scholar 

  • Hall, R. M., & Collis, C. M. (1995). Mobile gene cassettes and integrons: Capture and spread of genes by site-specific recombination. Mol Microbiol, 15, 593–600.

    PubMed  CAS  Google Scholar 

  • Hancock, R. E., & Lehrer, R. (1998). Cationic peptides: A new source of antibiotics. Trends Biotechnol, 16, 82–88.

    Article  PubMed  CAS  Google Scholar 

  • Hanberger, H., García-Rodriguez, J. A., Gobernado, M., Groossens, H., Nilsson, L. E., & Struelens, M. J. (1999). Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. JAMA, 281, 67–71.

    Article  PubMed  CAS  Google Scholar 

  • Hanberger, H., Diekema, D., Fluit, A., Jones, R., Struelens, M., Spencer, M., & Wolff, M. (2001). Surveillance of antibiotic resistance in European ICUs. J Hosp Infect, 48, 161–176.

    Article  PubMed  CAS  Google Scholar 

  • Heisig, P. (1996). Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother, 40, 879–885.

    PubMed  CAS  Google Scholar 

  • Höiby, N. (2000). Ecological antibiotic policy. J Antimicrob Chemother, 46, 59–62.

    Google Scholar 

  • Hoiseth, S. K., & Stocker, B. A. (1981). Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature, 291, 238–239.

    Article  PubMed  CAS  Google Scholar 

  • Hooker, K. D., & Di Piro, J. T. (1988). Effect of antimicrobial therapy on bowel flora. Clin Pharm, 7, 878–888.

    PubMed  CAS  Google Scholar 

  • Hooper, D. C. (1999). Mechanisms of fluoroquinolone resistance. Drug Resist Updates, 2, 38–55.

    CAS  Google Scholar 

  • Hooper, D. C. (2000). New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis, 30, 243–254.

    Article  PubMed  CAS  Google Scholar 

  • Hooper, D. C. (2001). Mechanisms of action of antimicrobials: Focus on fluoroquinolones. Clin Infect Dis, 32, S9–S15.

    Article  PubMed  CAS  Google Scholar 

  • Hughes, V M., & Datta, N. (1983). Conjugative plasmids in bacteria of the “pre-antibiotic” era. Nature, 302, 725–726.

    PubMed  CAS  Google Scholar 

  • Ishii, H., Sato, K., Hoshino, K., Sato, M., Yamaguchi, A., Sawai, T., & Osada, Y. (1991). Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus vulgaris. J Antimicrob Chemother, 28, 827–836.

    PubMed  CAS  Google Scholar 

  • Ito, H., Arakawa, Y., Ohsuka, S., Wacharotayanku, R., Kato, N., & Ohta, M. (1995). Plasmid-mediated dissemination of metallo β-lactamase gen bla IMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother, 39, 824–829.

    PubMed  CAS  Google Scholar 

  • Jacoby, G. A., & Sutton, L. (1991). Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemother, 35, 164–169.

    PubMed  CAS  Google Scholar 

  • John, J. F., & Rice, L. B. (2000). The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol, 21, S22–S31.

    PubMed  Google Scholar 

  • Johnson, D. M., & Jones, R. N. (1996). Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against Gram-positive species. Diagn Microbiol Infect Dis, 24, 53–57.

    Article  PubMed  CAS  Google Scholar 

  • Jones, R. N. (1992). The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens. Diagn Microbiol Infect Dis, 15, 3S–10S.

    PubMed  CAS  Google Scholar 

  • Kaye, K. S., Cosgrove, S., Harris, A., Eliopoulos, G. M., & Carmeli, Y. (2001). Risk factors for emergence of resistance to broad spectrum cephalosporin among Enterobacter spp. Antimicrob Agents Chemother, 45, 2628–2630.

    Article  PubMed  CAS  Google Scholar 

  • Knox, J. R. (1995). Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: Mutations, specificity and three-dimensional structure. Antimicrob Agents Chemother, 39, 2593–2601.

    PubMed  CAS  Google Scholar 

  • Kobayashi, N., Nishino, K., & Yamaguchi, A. (2001) Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol, 183, 5639–5644.

    PubMed  CAS  Google Scholar 

  • Kollef, M. H. (2001). Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med, 29, N135–N142.

    PubMed  CAS  Google Scholar 

  • Kollef, M. H., & Fraser, V J. (2001). Antibiotic resistance in the intensive care unit. Ann In Med, 134, 298–314.

    CAS  Google Scholar 

  • Kollef, M. H., Vlasnik, J., Sharpless, L., Pasque, C., Murphy, D., & Fraser, V. (1997). Schedule rotation of antibiotic classes. A strategy to decrease the incidence of ventilator associated pneumonia due to antibiotic-resistant Gram-negative bacteria. Am J Respir Crit Care Med, 156, 1040–1048.

    PubMed  CAS  Google Scholar 

  • Kollef, M. H., Ward, S., Sherman, G., Prentice, D., Schaiff, R., Huey, W., & Fraser, V. (2000). Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choice. Crit Care Med, 28, 3456–3464.

    PubMed  CAS  Google Scholar 

  • Laraki, N., Galleni, M., Thamm, I., Riccio, M. L., Amicosante, G., Frère, J. M., & Rossolini, G. M. (1999). Structure of In31, abla IMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob Agents Chemother, 43, 890–901.

    PubMed  CAS  Google Scholar 

  • Le Thomas, I., Coutdic, G., Clermont, O., Brahimi, N., Plesiat, P., & Bingen, E. (2001). In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy. J Antimicrob Chemother, 48, 553–555.

    PubMed  Google Scholar 

  • Levine, M. M., & Noriega, F. (1995). A review of the current status of enteric vaccines. P N G Med J, 38, 325–331.

    PubMed  CAS  Google Scholar 

  • Levy, S. B. (1997). Antibiotic resistance: An ecological imbalance. Ciba Found Symp, 207, 1–9.

    PubMed  CAS  Google Scholar 

  • Lipsitch, M., & Levin, B. R. (1997). The population dynamics of antimicrobial chemotherapy. Antimicrob Agents Chemother, 41, 363–373.

    PubMed  CAS  Google Scholar 

  • Livermore, D. M. (1995). β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev, 8, 557–584.

    PubMed  CAS  Google Scholar 

  • Livermore, D. M., & Yuan, M. (1996). Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother, 38, 409–424.

    PubMed  CAS  Google Scholar 

  • Livermore, D. M., & Woodford, N. (2000). Carbapenemases: A problem in waiting? Curr Opin Microbiol, 3, 489–495.

    PubMed  CAS  Google Scholar 

  • Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S., Watkins, W., Hoshino, K., Ishida, H., & Lee, V. J. (2001). Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy. Antimicrob Agents Chemother, 45, 105–116.

    Article  PubMed  CAS  Google Scholar 

  • Lowe, M. N., & Lamb, H. M. (2000). Gemifloxacin. Drugs, 59, 1137–1147.

    PubMed  CAS  Google Scholar 

  • Lu, T., Zhao, X., & Drlica, K. (1999). Gatifloxacin activity against quinolone-resistant gyrase: Allele-specific enhancement of bacteriostatic bactericidal activities by the C-8-methoxy group. Antimicrob Agents Chemother, 43, 2969–2974.

    PubMed  CAS  Google Scholar 

  • Maiti, S. N., Phillips, O. A., Micetich, R. G., & Livermore, D. M. (1998). Beta-lactamase inhibitors: Agents to overcome bacterial resistance. Curr Med Chem, 5, 441–456.

    PubMed  CAS  Google Scholar 

  • Martínez, J. L., & Baquero, F. (2000). Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother, 44, 1771–1777.

    PubMed  Google Scholar 

  • Martínez, J. L., Cercenado, E., Rodríguez-Creixems, M., Vicente-Pérez, M. F., Delgado-Iribarren, A., & Baquero, F. (1987). Resistance to beta-lactam/clavulanate. Lancet, 8573, 1473.

    Google Scholar 

  • Martínez, J. L., Vicente, M. F., Delgado-Iribarren, A., Pérez-díaz, J. C., & Baquero, F. (1989). Small plasmids are involved in amoxycillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother, 33, 595.

    PubMed  Google Scholar 

  • Martínez-Freijó, P., Fluit, A. C., Schmitz, F. J., Grek, V S. C., Verhoef, J., & Jones, M. E. (1998). Class 1 integrons in Gram-negative isolates from different European hospitals and associations with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother, 42, 689–696.

    PubMed  Google Scholar 

  • Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998). Quinolone resistance from a transferable plasmid. Lancet, 351, 797–799.

    PubMed  Google Scholar 

  • Martínez-Suárez, J., Martinez, J. L., López de Goicoechea, M. J., Pérez-Díaz, J. C., Baquero, F., Meseguer, M., & Baquero, F. (1987). Acquisition of antibiotic resistance plasmids in vivo by extraintestinal Salmonella spp. J Antimicrob Chemother, 20, 452–453.

    PubMed  Google Scholar 

  • Mason, H. S., Haq, T. A., Clements, J. D., & Arntzen, C. J. (1998). Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene. Vaccine, 16, 1336–1343.

    Article  PubMed  CAS  Google Scholar 

  • Mazzariol, A., Tokue, Y., Kanegawa, T. M., Cornaglia, G., & Nikaido, H. (2000). High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother, 44, 3441–3443.

    PubMed  CAS  Google Scholar 

  • McGowan, J. E., Jr. (2000). Strategies for study of the role of cycling on antimicrobial use and resistance. Infect Control Hasp Epidemiol, 21, S36–S43.

    Google Scholar 

  • McGowan, J. E., Jr., & Gerding, D. N. (1996). Does antibiotic restriction prevent resistance? New Horiz, 4, 370–376.

    PubMed  Google Scholar 

  • McGowan, J. E., & Tenover, F. C. (1997). Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am, 11, 297–311.

    PubMed  Google Scholar 

  • Mebis, J., Goossens, H., Bryneel, P., Sion, J. P., Meeus, I., van Droogenbroeck, J., Schroyens, W., & Berneman, Z. N. (1998). Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy by neutropenic fever patients. Leukemia, 12, 1627–1629.

    Article  PubMed  CAS  Google Scholar 

  • Medeiros, A. A. (1997). Evolution and dissemination of β-lactamases accelerated by generations of β-lactamases antibiotics. Clin Infect Dis, 24, S19–S45.

    PubMed  CAS  Google Scholar 

  • Mendez, B., Tachibana, C., & Levy, S. B. (1980). Heterogeneity of tetracycline resistance determinants. Plasmid, 3, 99–108.

    Article  PubMed  CAS  Google Scholar 

  • Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993). Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med, 119, 353–358.

    PubMed  CAS  Google Scholar 

  • Miyazaki, S., Hosoyama, T., Furuya, N., Ishii, Y., Matsumoto, T., Ohno, A., Tateda, K., & Yamaguchi, K. (2001). In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections. Antimicrob Agents Chemother, 82, 203–207.

    Google Scholar 

  • Moken, M. C., McMurry, L. M., & Levy, S. B. (1997). Selection of multiple-antibiotic-resistant (Mar) mutants of Escherichia coli by using the disinfectant pine oil: Roles of the mar and acrAB loci. Antimicrob Agents Chemother, 41, 2770–2772.

    PubMed  CAS  Google Scholar 

  • Monroe, S., & Polk, R. (2000). Antibimicrobial use and bacterial resistance. Curr Opin Microbiol, 3, 496–501.

    Article  PubMed  CAS  Google Scholar 

  • Morosini, M. I., Ayala, J. A., Baquero, F., Martínez, J. L., & Blazquez, J. (2000). Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother, 44, 3137–3143.

    Article  PubMed  CAS  Google Scholar 

  • Nakamura, S. (1997). Mechanisms of quinolone resistance. J Infect Chemother, 3, 128–138.

    CAS  Google Scholar 

  • Neu, H. C. (1992). The crisis in antibiotic resistance. Science, 257, 1064–1073.

    PubMed  CAS  Google Scholar 

  • Nicolle, L. E. (2001). Preventing infections in non-hospital settings: Long-term care. Emerg Infect Dis, 7, 205–207.

    PubMed  CAS  Google Scholar 

  • Nikaido, H. (1998). Multiple antibiotic resistance and efflux. Curr Opin Microbiol, 1, 516–523.

    Article  PubMed  CAS  Google Scholar 

  • Nishino, Y., Deguchi, T., Yasuda, M., Kawamura, T., Nakano, M., Kanematsu, E., Ozeki, S., & Kawada, Y. (1997). Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundii. FEMS Microbiol Lett, 154, 409–414.

    Article  PubMed  CAS  Google Scholar 

  • NNIS. (1999). Intensive Care Antimicrobial Resistance Epidemiology (ICARE) surveillance report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control, 27, 279–284.

    Google Scholar 

  • Nordmann, P. (1998). Trends in β-lactant resistance among Enterobacteriaceae. Clin Infect Dis, 27, S1000–S1006.

    Google Scholar 

  • Oethinger, M., Kern, W. V., Jellen-Ritter, A. S., McMurry, L. M., & Levy, S. B. (2000). Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother, 44, 10–13.

    Article  PubMed  CAS  Google Scholar 

  • Okusu, H., Ma, D., & Nikaido, H. (1996). AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacterial, 178, 306–308.

    CAS  Google Scholar 

  • Oliver, A., Pérez-Díaz, J. C., Coque, T. M., Baquero, F., & Cantón, R. (2000). Nucleotide sequence and characterization of a novel cetotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother, 44, 2549–2553.

    PubMed  Google Scholar 

  • Onion, C. W., & Bartzokas, C. A. (1998). Changing attitudes to infection management in primary care: A controlled trial of active versus passive guideline implementation. Farm Pract, 15, 99–104.

    CAS  Google Scholar 

  • Osano, E., Arakawa, Y., Wacharotayankum, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994). Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother, 38, 71–78.

    PubMed  CAS  Google Scholar 

  • Osterblad, M., Hakanen, A., Manninen, R., Leistevuo, T., Peltonen, R., Meurman, O., Huovinen, P., & Kotilainen, P. (2000). A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother, 44, 1479–1484.

    Article  PubMed  CAS  Google Scholar 

  • Papanicolaou, G. A., Medeiros, A. A., & Jacoby, G. A. (1990). Novel-plasmid mediated βlactamase (MIR-1) conferring resistance to oxyimino-and α-methoxy β-lactamas inclinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother, 34, 2200–2209.

    PubMed  CAS  Google Scholar 

  • Paterson, D.L., Mulazimoglu, L., Casellas, J.M., Ko, W.C., Goosens, H., Von Gottberg, A., Mohapatra, S., Trenholme, G. M., Klugman, K. P., McCormack, J. G., & Yu, V. L. (2000). Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis, 30, 473–478.

    Article  PubMed  CAS  Google Scholar 

  • Paterson, D. L., Singh, N., Rihs, J. D., Squier, C., Rihs, B. L., & Muder, R. R. (2001). Control of an outbreak of infection due to extended-spectrum ESBL producing E. coli in a liver transplantation unit. Clin Infect Dis, 33, 126–128.

    Article  PubMed  CAS  Google Scholar 

  • Peng, H., & Marians, K. J. (1993). Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. J Biol Chem, 268, 24481–24490.

    PubMed  CAS  Google Scholar 

  • Peña, C., Pujol, M., Ardanuy, C., Ricart, A., Pallares, R., Linares, J., Ariza, J., & Gudiol, F. (1998). Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases, Antimicrob Agents Chemother, 42, 53–58.

    PubMed  Google Scholar 

  • Perry, C. M., Barman Balfour, J. A., & Lamb, H. M. (1999). Gatifloxacin. Drugs, 58, 683–696.

    PubMed  CAS  Google Scholar 

  • Pestotnik, S. L., Classen, D. C., Evans, R. S., & Burke, J. P. (1996). Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med, 12, 884–890.

    Google Scholar 

  • Philippon, A., Arlet, G., & Lagrange, P. H. (1994). Origin and impact of plasmid-mediated of extended spectrum β-lactamases, Eur J Clin Microbiol Infect Dis, 13, S17–S29.

    PubMed  Google Scholar 

  • Philippon, A., Arlet, G., & Jacoby, G.A. (2002). Plasmid-determined AmpC-type β-lactamases Antimicrob Agents Chemother, 46, 1–11.

    Article  PubMed  CAS  Google Scholar 

  • Piddock, L. J. V (1999). Mechanisms of fluoroquinolone resistance: An update 1994–1998. Drugs, 58, S11–S18.

    Google Scholar 

  • Poirel, L., Naas, T., Guibert, M., Chaibi, E. B., Labia, R., & Nordmann, P. (1999). Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother, 43, 573–581.

    PubMed  CAS  Google Scholar 

  • Poirel, L., Le Thomas, I., Naas, T., Karim, A., & Nordmann, P. (2000). Biochemical sequence analysis of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 Integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother, 44, 622–632.

    PubMed  CAS  Google Scholar 

  • Poole, K. (2000). Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob Agents Chemother, 44, 2233–2241.

    PubMed  CAS  Google Scholar 

  • Price, D.J.E., & Sleigh, J.D. (1970). Control infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet, 7685, 1213–1215.

    Google Scholar 

  • Prinarakis, E. E., Miriagou, V., Tzelepi, E., Gazouli, M., & Tzouvelekis, L. S. (1997). Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob Agents Chemother, 41, 838–840.

    PubMed  CAS  Google Scholar 

  • Quinn, J.P. (1998). Clinical problems posed by multiresistant nonfermenting Gram-negative pathogens. Clin Infect Dis, 27, S117–S124.

    Article  PubMed  CAS  Google Scholar 

  • Rahal, J. J., Urban, C., Horn, D., Freeman, K., Segal-Maurer, S., Maurer, J., Mariano, N., Marks, S., Burns, J. M., Dominick, D., & Lim, M. (1998). Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA, 280, 1233–1237.

    Article  PubMed  CAS  Google Scholar 

  • Reguera, J. A., Baquero, F., Pérez-Díaz, J. C., & Martínez, J. L. (1991). Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother, 27, 569–575.

    PubMed  CAS  Google Scholar 

  • Rice, L. B., Eckstein, E. C., DeVente, J., & Shlaes, D. M. (1996). Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veteran Affairs Medical Center. Clin Infect Dis, 23, 118–124.

    PubMed  CAS  Google Scholar 

  • Richard, P., Delangle, M. H., Raffi, F., Espaze, E., & Richet, H. (2001). Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant Gram-negative bacilli from gas-trointestinal flora. Clin Infect Dis, 32, 162–166.

    Article  PubMed  CAS  Google Scholar 

  • Rowe-Magnus, D. A., & Mazel, D. (1999). Resistance gene capture. Curr Opin Microbiol, 2, 483–88.

    Article  PubMed  CAS  Google Scholar 

  • Saez-Llorens, X., Castrejon de Wong, M. M., Castano, E., De Suman, O., De Moros, D., & De Atencio, I. (2000). Impact of an antibiotic restriction policy on a hospital expenditures and bacterial susceptibility: A lesson from a pediatric institution in a developing country. Ped Infect Dis J, 19, 200–206.

    CAS  Google Scholar 

  • Saier, M. H., Paulsen, I. T., Sliwinski, M. K., Pao, S. S., Skurray, R. A., & Nikaido, H. (1998). Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J, 12, 265–274.

    PubMed  CAS  Google Scholar 

  • Sanders, W. E., Jr., & Sanders, C. C. (1997). Circumventing antibiotic resistance in specialized hospital units. Clin Microbiol Infect, 3, 272–273.

    PubMed  Google Scholar 

  • Schmitz, F. J., Hafher, D., Geisel, R., Follmann, P., Kirschke, C., Verhoef, J., Kohrer, K., & Fluit, A. C. (2001). Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital. J Clin Microbiol, 39, 3724–3726.

    Article  PubMed  CAS  Google Scholar 

  • Shannon, K., Stapleton, P., Xiang, X., Johnson, A., Beattie, H., El Bakri, F., Cookson, B., & French, G. (1998). Extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol, 36, 3105–3110.

    PubMed  CAS  Google Scholar 

  • Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev, 57, 138–163.

    PubMed  CAS  Google Scholar 

  • Shlaes, D. M., Gerding, D. N., John, J. F., Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., Levy, S., McGowan, J. E., Jr., Paul, S. M., Ruskin, J., Tenover, F. C., & Watanakunakorn, C. (1997). Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hasp Epidemiol, 18, 275–291.

    CAS  Google Scholar 

  • Sougakoff, W, Petit, A., Goussard, S., Sirot, D., Bur, A., & Courvalin, P. (1989). Characterization of the plasmid genes bla T-4 and bla T-5 which encode the broad-spectrum β-lactamases. Gene, 78, 339–348.

    Article  PubMed  CAS  Google Scholar 

  • Struelens, M. J., Bly, B., Govaerts, D., De Gheldre, Y., Jacibs, E., Thys, J. P., Lievin, V, & Vincent, J. L. (1998). Modification of antibiotic policy associated with decrease in antibiotic-resistant Gram-negative bacilli in intensive care units. (Abstract K12). In Programs and abstracts 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiolgy, p. 502.

    Google Scholar 

  • Struelens, M. J., Byl, B., & Vincent, J. L. (1999). Antibiotic policy: A tool for controlling resistance of hospital pathogens. Clin Microbiol Infect, 5, S19–S24.

    Article  PubMed  Google Scholar 

  • Sulavik, M. C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., DiDomenico, B., Shaw, K. J., Miller, G. H., Hare, R., & Shinier, G. (2001). Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother, 45, 1126–1136.

    Article  PubMed  CAS  Google Scholar 

  • Sum, P. E., Sum, F. W., & Projan, S. J. (1998). Recent developments in tetracycline antibiotics. Curr Pharm Des, 4, 119–132.

    PubMed  CAS  Google Scholar 

  • Swartz, M. N. (1994). Hospital-acquired infections: Diseases with increasingly limited therapies. Proc Natl Acad Sci USA, 91, 2420–2427.

    PubMed  CAS  Google Scholar 

  • Tan, Y. T., Tillett, D. J., & McKay, I. A. (2000). Molecular strategies for overcoming antibiotic resistance in bacteria. Mol Med Today, 6, 309–314.

    PubMed  CAS  Google Scholar 

  • Thomson, K. S. (2001). Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis, 7, 333–336.

    Article  PubMed  CAS  Google Scholar 

  • Toltzis, P., Yamashita, T., Vilt, L., Green, M., Morrissey, A., Spinner-Block, S., & Blumer, J. (1998). Antibiotic restriction does not alter endemic colonization with resistant Gram-negative rods in a pediatric intensive care unit. Crit Care Med, 26, 1893–1899.

    PubMed  CAS  Google Scholar 

  • Trouillet, J. L., Chastre, J., Vuagnat, A., Joly-Guillou, M. L., Combaux, D., Dombret, M. C., & Gibert, C. (1998). Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med, 157, 531–539.

    PubMed  CAS  Google Scholar 

  • Truong, Q. C., Quabdesselam, S., Hooper, D. C., Moreau, N. J., & Soussy, C. J. (1995). Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy. J Antimicrob Chemother, 36, 1055–1059.

    PubMed  CAS  Google Scholar 

  • Tzouvelekis, L.S., & Bonomo, R. A. (1999). SHV-type β-lactanases. Curr Pharmaceut Des, 5, 847–864.

    CAS  Google Scholar 

  • Tzouvelekis, L. S., Tzelepi, E., Tassios, P. X, & Legakis, N. J. (2000). CTX-M-Type β-lactamases An emerging group of extended-spectrum enzymes. Int J Antimicrob Agents, 14, 137–142.

    PubMed  CAS  Google Scholar 

  • Urban, C., Mariano, N., Rahman, N., Queena, A., Montenegro, D., Bush, K., & Rahal, J. J. (2000). Detection of multirresistant ceftazidime-susceptible Klebsiella pneumonias isolates lacking TEM-26 after class restriction of cephalosporins. Microb Drug Resist, 6, 297–303.

    Article  PubMed  CAS  Google Scholar 

  • Van Belkum, A., Goessens, W., van Der Schee, C., Lemmens-Den Toom, N., Vos, M. C., Cornelissen, J., Lugtenburg, E., de Marie, S., Verbrugh, H., Lowenberg, B., & Endtz, H. (2001). Rapid emergence of ciprofloxacin-resistant Enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerging Infect Dis, 7, 862–871.

    PubMed  Google Scholar 

  • Van der Zwet, W. C., Parlevliet, G. A., Savelkoul, P. H., Stoof, J., Kaiser, A. M., Koeleman, J. G., & Vandenbroucke-Grauls, C.M. (1999). Nosocomial outbreak of gentamicin-resistant Klebsiella pneumoniae in a neonatal intensive care unit controlled by change in antibiotic policy. J Hosp Infect, 42, 295–302.

    Article  PubMed  Google Scholar 

  • Van Kraaij, M. G., Dekker, A. W, Peters, E., Fluit, A., Verdonck, L. F., & Rozenberg-Arska, M. (1998). Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients. EurJ Clin Microbiol Infect Dis, 17, 591–592.

    Google Scholar 

  • Verhoef, J., Acar, J. F., Gupta, R., & Jones, R. (1999). Surveillance of resistance against antimicrobial agents. Int J Antimicrob Agents, 12, 77–79.

    PubMed  CAS  Google Scholar 

  • Vila, J., Ruiz, J., Marco, F., Barcelo, A., Goái, P., Giralt, E., & Jimenez de Anta, T. (1994). Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother, 38, 2477–2479.

    PubMed  CAS  Google Scholar 

  • Wagenlehner, F, Stower-Hoffmann, J., Schneider-Brachert, W., Naber, K. G., & Lehn, N. (2000). Influence of prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents, 15, 207–211.

    PubMed  CAS  Google Scholar 

  • Weigel, L. M., Steward, C. D., & Tenover, F. (1998). gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother, 42, 2661–2667.

    PubMed  CAS  Google Scholar 

  • Weiss, W. J., Mikels, S. M., Petersen, P. J., Jacobus, N. V., Bitha, P., Lin, Y. I., & Testa, R. T. (1999). In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems. Antimicrob Agents Chemother, 43, 460–464.

    PubMed  CAS  Google Scholar 

  • Weston, G. S., Blazquez, J., Baquero, F., & Shoichet, B. K. (1998). Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem, 41, 4577–4586.

    Article  PubMed  CAS  Google Scholar 

  • White, A.C., Jr., Atmar, R.L., Wilson, J., Cate, T.R., Stager, C.E., & Greenberg, S.B. (1997). Effects of requiring prior authorization for selected antimicrobials expenditures, susceptibility, and clinical outcomes. Clin Infect Dis, 25, 230–239.

    PubMed  Google Scholar 

  • White, P.A., McIver, C.J., & Rawlinson, W.D. (2001). Integrons and gen cassetes in the Enterobacteriaceae. Antimicrob Agents Chemother, 45, 2658–2661.

    Article  PubMed  CAS  Google Scholar 

  • White, R. L., Friedrich, L. V, Mihm, L. B., & Bosso, J. A. (2000). Assessment of the relationship between antimicrobial usage and susceptibility: Differences between hospitals and specific patient-care areas. Clin Infect Dis, 31, 16–23.

    Article  PubMed  CAS  Google Scholar 

  • Wiener, J., Quinn, J. P., Bradford, P. A., Goering, R. V, Nathan, C., Bush, K., & Weinstein, R. A. (1999). Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA, 281, 517–523.

    Article  PubMed  CAS  Google Scholar 

  • Winokour, P. L., Cantón, R., Casellas, J. M, & Legakis, N. (2001). Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis, 32, S94–S103.

    Google Scholar 

  • World Health Organization. (2000). Overcoming antibiotic resistance. World Health Organization Report in Infectious Diseases 2000.

    Google Scholar 

  • Yates, R.R. (1999). New intervention strategies for reducing antibiotic resistance. Chest, 115, 24S–27S.

    Article  PubMed  CAS  Google Scholar 

  • Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sánchez, A., Biddle, J. W, Steward, C. H. D., Alberti, S., Bush, K., & Tenover, F. (2001). Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother, 45, 1151–1161.

    Article  PubMed  CAS  Google Scholar 

  • Yuan, M., Aucken, H., Hall, L. M. C., Pitt, T. L., & Livermore, D. M. (1998). Epidemiological typing of Klebsiellae with extended-spectrum β-lactamases from European intensive care units. J Antimicrob Chemother, 41, 527–539.

    Article  PubMed  CAS  Google Scholar 

  • Zervos, M.J., Bacon, A.E., Patterson, J.E., Schaberg, D.R., & Kauffman, C.A. (1988). Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother, 21, 113–115.

    PubMed  CAS  Google Scholar 

  • Zhao, X., Xu, C., Domagala, J., & Drlica, K. (1997). DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance. Proc Natl Acad Sci USA, 94, 13991–13996.

    PubMed  CAS  Google Scholar 

  • Zhao, X., & Drlica, K. (2001). Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies. Clin Infect Dis, 33, S147–S156.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, J., Dong, Y, Zhao, X., Lee, S., Amin, A., Ramaswamy, S., Domagala, J., Musser, J.M., & Drlica, K. (2000). Selection of antibiotic-resistant bacterial mutants: Allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis, 182, 517–525.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Maria I. Morosini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rafael Cantón
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José L. Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Michael’s Hospital, University of Toronto Head of Infectious Diseases, Canada

    I. W. Fong

  2. St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

    I. W. Fong

  3. The Public Health Research Institute, Newark, New Jersey

    Karl Drlica

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Morosini, M.I., Cantón, R., Martínez, J.L. (2004). Multi-resistant Enterobacteriaceae in Hospital Practice. In: Fong, I.W., Drlica, K. (eds) Reemergence of Established Pathogens in the 21st Century. Emerging Infectious Diseases of the 21st Century, vol 2. Springer, Boston, MA. https://doi.org/10.1007/0-306-48411-0_6

Download citation

  • DOI: https://doi.org/10.1007/0-306-48411-0_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-47500-9

  • Online ISBN: 978-0-306-48411-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation